NCAPG2 is a diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
Current research indicates that NCAPG2 may provide effective assistance for the early diagnosis and pathological classification of CHOL, potentially regulating the immune microenvironment and thereby influencing the occurrence and progress of CHOL.
Authors
- Zhaojun Huang
- Xiaoming Wei
- Xiaohang Niu (ORCID: https://orcid.org/0009-0008-9711-3701)
- Mingjin Zhang (ORCID: https://orcid.org/0000-0002-1653-108X)
Institutions
- 81th Hospital of PLA (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1007/s12672-025-02809-4
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00